share_log

Biogen Posts Higher 4Q Earnings >BIIB

Dow Jones Newswires ·  Jan 30, 2020 07:19

DJ Biogen Posts Higher 4Q Earnings >BIIB

By Amber Burton

Biogen Inc. (BIIB) reported higher earnings in the latest quarter, beating analysts' expectations.

The Cambridge, Mass., biopharmaceutical company on Thursday said its fourth-quarter earnings were $1.44 billion, or $8.08 a share, compared with $947 million, or $4.73 a share a year earlier.

Adjusted earnings for the quarter were $8.34 a share. Analysts polled by FactSet were expecting adjusted earnings of $8.02 a share.

Total revenue was $3.67 billion, up from $3.53 billion a year earlier. Analysts were expecting revenue of $3.54 billion.

Write to Amber Burton at amber.burton@wsj.com

(END) Dow Jones Newswires

January 30, 2020 07:19 ET (12:19 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment